Takeda Completes Acquisition of Shire, Becoming a Global, Values-Based, R&D-Driven Biopharmaceutical Leader

Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (Takeda) today announced the completion of its acquisition of Shire plc (Shire), becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan.